Multicenter Evaluation of a Fully Automated High-Throughput SARS-CoV-2 Antigen Immunoassay.

Dominik NörzFlaminia OlearoStojan PerisicMatthias F BauerElena RiesterTanja SchneiderKathrin SchönfeldTina LaenginMarc Lütgehetmann

Published in: Infectious diseases and therapy (2021)

The Elecsys SARS-CoV-2 Antigen assay reliably detected patient samples with viral loads ≥ 10,000 copies/ml. It thus represents a viable high-throughput alternative for screening of patients or in situations where PCR testing is not readily available.

Keyphrases

high throughput
sars cov
end stage renal disease
respiratory syndrome coronavirus
single cell
ejection fraction
newly diagnosed
peritoneal dialysis
chronic kidney disease
case report
patient reported outcomes
deep learning